Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Celsa

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Diagnostics (Basel, Switzerland)|June 24, 2022
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCCRoberto Cannella, Carla Cammà, Francesco Matteini, et al.
JHEP Reports : Innovation in Hepatology|June 6, 2026
PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: a meta-analysis of observational studiesCiro Celsa, Grazia Pennisi, Adele Tulone, et al.
Journal of Hepatology|May 2, 2025
Hepatocellular carcinoma in people living with HIVClaudia Am Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 15, 2022
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysisGrazia Pennisi, Ciro Celsa, Marco Enea, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2021
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antiviralsRoberto Cannella, Federica Vernuccio, Ciro Celsa, et al.
Gastrointestinal Endoscopy|July 21, 2022
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual dataMatteo Tacelli, Niccolò Bina, Stefano Francesco Crinò, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLDGrazia Pennisi, Marco Enea, Alessandra Pandolfo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver DiseaseStefania Grimaudo, Rosaria Maria Pipitone, Grazia Pennisi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2025
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-AnalysisGrazia Pennisi, Gabriele Di Maria, Marco Enea, et al.
Liver Cancer|February 28, 2022
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Maria Reig, Ciro Celsa, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Diagnostics (Basel, Switzerland)|June 24, 2022
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCCRoberto Cannella, Carla Cammà, Francesco Matteini, et al.
JHEP Reports : Innovation in Hepatology|June 6, 2026
PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: a meta-analysis of observational studiesCiro Celsa, Grazia Pennisi, Adele Tulone, et al.
Journal of Hepatology|May 2, 2025
Hepatocellular carcinoma in people living with HIVClaudia Am Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 15, 2022
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysisGrazia Pennisi, Ciro Celsa, Marco Enea, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2021
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antiviralsRoberto Cannella, Federica Vernuccio, Ciro Celsa, et al.
Gastrointestinal Endoscopy|July 21, 2022
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual dataMatteo Tacelli, Niccolò Bina, Stefano Francesco Crinò, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 16, 2022
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLDGrazia Pennisi, Marco Enea, Alessandra Pandolfo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 17, 2019
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver DiseaseStefania Grimaudo, Rosaria Maria Pipitone, Grazia Pennisi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2025
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-AnalysisGrazia Pennisi, Gabriele Di Maria, Marco Enea, et al.
Liver Cancer|February 28, 2022
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Maria Reig, Ciro Celsa, et al.
Pageof 12